cert
cert-1
cert-2

Pass IAPP AIGP Exam in First Attempt Guaranteed!

Get 100% Latest Exam Questions, Accurate & Verified Answers to Pass the Actual Exam!
30 Days Free Updates, Instant Download!

cert-5
cert-6
AIGP Exam - Verified By Experts
AIGP Premium Bundle
$29.98

AIGP Premium Bundle

$79.99
$109.97
  • Premium File 222 Questions & Answers. Last update: Nov 15, 2026
  • Training Course 124 Video Lectures
  • Study Guide 566 Pages
 
$109.97
$79.99
accept 63 downloads in last 7 days
block-screenshots
Purchase IAPP AIGP Exam Training Products Individually
IAPP AIGP Premium File
Premium File 222 Q&A
$76.99$69.99
IAPP AIGP Video Training Course
Training Course 124 Lectures
$21.99 $19.99
IAPP AIGP PDF Study Guide
Study Guide 566 Pages
$21.99 $19.99
IAPP AIGP Practice Test 62

Question 610

A regulator-facing application selects a large opaque generative model for a repeatable arithmetic eligibility rule. A material training or architecture change makes the previous technical approval insufficient. What action should the accountable team prioritize to govern this use responsibly?

  1. Prefer eliminating or minimizing the hazard, then add technical barriers, human controls and communication safeguards.
  2. Choose an auditable rule-based or simpler model where it demonstrably satisfies the use case, with AI only where justified.
  3. Conduct an AI impact assessment with accessible stakeholder participation and documented mitigations.
  4. Write a bounded use-case specification with human authority, exclusions and measurable patient-safety objectives.

Explanation

Correct Answer

B:

Choose an auditable rule-based or simpler model where it demonstrably satisfies the use case, with AI only where justified. Correct. It directly reduces or governs the specific documented risk. Model selection is a governance choice about fit, controllability and risk, not model prestige.

Incorrect Answers

A:

Prefer eliminating or minimizing the hazard, then add technical barriers, human controls and communication safeguards. Not selected. That action treats another control objective, not the specific gap described. It belongs with Risk mitigation hierarchy: Risk treatment should prioritize effective hazard reduction over disclaimers that shift burden to users. The present case instead concerns System architecture and model choice.

C:

Conduct an AI impact assessment with accessible stakeholder participation and documented mitigations. Not selected. That action treats another control objective, not the specific gap described. It belongs with Stakeholder impact assessment: Impact assessment should consider people and groups who bear risk, not only the organization buying AI. The present case instead concerns System architecture and model choice.

D:

Write a bounded use-case specification with human authority, exclusions and measurable patient-safety objectives. Not selected. That action treats another control objective, not the specific gap described. It belongs with Use-case problem framing: A defensible AI design begins with the problem and context, not a preference for a model technology. The present case instead concerns System architecture and model choice.

Question 611

A regulator-facing application selects a large opaque generative model for a repeatable arithmetic eligibility rule. A material training or architecture change makes the previous technical approval insufficient. What result would provide the strongest case-specific assurance?

  1. Pilot representative workflows and compare outcomes with the agreed non-AI baseline.
  2. Measure performance on representative cohorts using the exact proposed production threshold.
  3. Test edge conditions and decision reproducibility against the documented model-selection criteria.
  4. Use adverse-case tests to show harm reduction from the chosen primary control, not just an acknowledgment banner.

Explanation

Correct Answer

C:

Test edge conditions and decision reproducibility against the documented model-selection criteria. Correct. It yields measurable evidence that the case-specific safeguard works. Model selection is a governance choice about fit, controllability and risk, not model prestige.

Incorrect Answers

A:

Pilot representative workflows and compare outcomes with the agreed non-AI baseline. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Use-case problem framing: A defensible AI design begins with the problem and context, not a preference for a model technology. The present case instead concerns System architecture and model choice.

B:

Measure performance on representative cohorts using the exact proposed production threshold. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Thresholds and acceptance metrics: Governance metrics should reflect the actual harm of error types, not aggregate accuracy alone. The present case instead concerns System architecture and model choice.

D:

Use adverse-case tests to show harm reduction from the chosen primary control, not just an acknowledgment banner. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Risk mitigation hierarchy: Risk treatment should prioritize effective hazard reduction over disclaimers that shift burden to users. The present case instead concerns System architecture and model choice.

Question 612

A regulator-facing application selects a large opaque generative model for a repeatable arithmetic eligibility rule. A material training or architecture change makes the previous technical approval insufficient. Which TWO actions form the appropriate investigation-and-control pair for this case?

  1. Identify affected populations, possible disparate impacts, appeal routes and missing stakeholder views.
  2. Choose an auditable rule-based or simpler model where it demonstrably satisfies the use case, with AI only where justified.
  3. Prefer eliminating or minimizing the hazard, then add technical barriers, human controls and communication safeguards.
  4. Compare requirements for determinism, explainability, resource cost, data needs and failure modes.

Explanation

Correct Answers

B:

Choose an auditable rule-based or simpler model where it demonstrably satisfies the use case, with AI only where justified. Correct. As the second, implementation half of the requested pair, this directly applies the needed safeguard. Model selection is a governance choice about fit, controllability and risk, not model prestige.

D:

Compare requirements for determinism, explainability, resource cost, data needs and failure modes. Correct. As the first, evidence-gathering half of the requested pair, this establishes the specific risk boundary. Model selection is a governance choice about fit, controllability and risk, not model prestige.

Incorrect Answers

A:

Identify affected populations, possible disparate impacts, appeal routes and missing stakeholder views. Not selected. It addresses a different governance mechanism, not the required assessment-and-control pair. It belongs with Stakeholder impact assessment: Impact assessment should consider people and groups who bear risk, not only the organization buying AI. The present case instead concerns System architecture and model choice.

C:

Prefer eliminating or minimizing the hazard, then add technical barriers, human controls and communication safeguards. Not selected. It addresses a different governance mechanism, not the required assessment-and-control pair. It belongs with Risk mitigation hierarchy: Risk treatment should prioritize effective hazard reduction over disclaimers that shift burden to users. The present case instead concerns System architecture and model choice.

Question 613

An AI-assisted diagnostic tool shows clinicians a label but auto-submits orders before they can review the evidence. The development team must show evidence before promoting the next model version. Before selecting a remedy, what should the accountable reviewer investigate first?

  1. Identify the decision, affected users, current baseline, proposed intervention and success criteria before selecting a model.
  2. Examine the actual intervention point, reviewer workload, authority and automation-bias risk.
  3. Identify affected populations, possible disparate impacts, appeal routes and missing stakeholder views.
  4. Compare requirements for determinism, explainability, resource cost, data needs and failure modes.

Explanation

Correct Answer

B:

Examine the actual intervention point, reviewer workload, authority and automation-bias risk. Correct. It establishes the relevant factual risk boundary before implementation. Human oversight works only when a person can understand, decide and intervene at the right time.

Incorrect Answers

A:

Identify the decision, affected users, current baseline, proposed intervention and success criteria before selecting a model. Not selected. That check primarily diagnoses a different governance issue. It belongs with Use-case problem framing: A defensible AI design begins with the problem and context, not a preference for a model technology. The present case instead concerns Human-in-the-loop design.

C:

Identify affected populations, possible disparate impacts, appeal routes and missing stakeholder views. Not selected. That check primarily diagnoses a different governance issue. It belongs with Stakeholder impact assessment: Impact assessment should consider people and groups who bear risk, not only the organization buying AI. The present case instead concerns Human-in-the-loop design.

D:

Compare requirements for determinism, explainability, resource cost, data needs and failure modes. Not selected. That check primarily diagnoses a different governance issue. It belongs with System architecture and model choice: Model selection is a governance choice about fit, controllability and risk, not model prestige. The present case instead concerns Human-in-the-loop design.

Question 614

An AI-assisted diagnostic tool shows clinicians a label but auto-submits orders before they can review the evidence. The development team must show evidence before promoting the next model version. What action should the accountable team prioritize to govern this use responsibly?

  1. Choose an auditable rule-based or simpler model where it demonstrably satisfies the use case, with AI only where justified.
  2. Write a bounded use-case specification with human authority, exclusions and measurable patient-safety objectives.
  3. Set risk-based precision, recall, fairness and escalation thresholds with business and affected-user input.
  4. Insert an effective clinician review and override before consequential orders are committed.

Explanation

Correct Answer

D:

Insert an effective clinician review and override before consequential orders are committed. Correct. It directly reduces or governs the specific documented risk. Human oversight works only when a person can understand, decide and intervene at the right time.

Incorrect Answers

A:

Choose an auditable rule-based or simpler model where it demonstrably satisfies the use case, with AI only where justified. Not selected. That action treats another control objective, not the specific gap described. It belongs with System architecture and model choice: Model selection is a governance choice about fit, controllability and risk, not model prestige. The present case instead concerns Human-in-the-loop design.

B:

Write a bounded use-case specification with human authority, exclusions and measurable patient-safety objectives. Not selected. That action treats another control objective, not the specific gap described. It belongs with Use-case problem framing: A defensible AI design begins with the problem and context, not a preference for a model technology. The present case instead concerns Human-in-the-loop design.

C:

Set risk-based precision, recall, fairness and escalation thresholds with business and affected-user input. Not selected. That action treats another control objective, not the specific gap described. It belongs with Thresholds and acceptance metrics: Governance metrics should reflect the actual harm of error types, not aggregate accuracy alone. The present case instead concerns Human-in-the-loop design.

Question 615

An AI-assisted diagnostic tool shows clinicians a label but auto-submits orders before they can review the evidence. The development team must show evidence before promoting the next model version. What result would provide the strongest case-specific assurance?

  1. Challenge the system with adversarial documents and confirm no secret disclosure or unauthorized tool action.
  2. Use adverse-case tests to show harm reduction from the chosen primary control, not just an acknowledgment banner.
  3. Measure performance on representative cohorts using the exact proposed production threshold.
  4. Test whether clinicians can reject the suggestion without workflow pressure and log their rationale.

Explanation

Correct Answer

D:

Test whether clinicians can reject the suggestion without workflow pressure and log their rationale. Correct. It yields measurable evidence that the case-specific safeguard works. Human oversight works only when a person can understand, decide and intervene at the right time.

Incorrect Answers

A:

Challenge the system with adversarial documents and confirm no secret disclosure or unauthorized tool action. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Generative AI misuse threat model: Generative AI development requires threat modeling for instruction confusion and downstream actions. The present case instead concerns Human-in-the-loop design.

B:

Use adverse-case tests to show harm reduction from the chosen primary control, not just an acknowledgment banner. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Risk mitigation hierarchy: Risk treatment should prioritize effective hazard reduction over disclaimers that shift burden to users. The present case instead concerns Human-in-the-loop design.

C:

Measure performance on representative cohorts using the exact proposed production threshold. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Thresholds and acceptance metrics: Governance metrics should reflect the actual harm of error types, not aggregate accuracy alone. The present case instead concerns Human-in-the-loop design.

Question 616

An AI-assisted diagnostic tool shows clinicians a label but auto-submits orders before they can review the evidence. The development team must show evidence before promoting the next model version. What should the owner do to prevent further harm from this specific failure?

  1. Stop high-severity deployments when credible harms exceed accepted residual-risk limits.
  2. Disable auto-ordering where meaningful clinical oversight is absent.
  3. Disable the harmful capability if residual risk remains beyond tolerance after feasible mitigation.
  4. Do not approve development scope until benefits, user responsibilities and safety constraints are defined.

Explanation

Correct Answer

B:

Disable auto-ordering where meaningful clinical oversight is absent. Correct. It limits further reliance or exposure while the risk remains unresolved. Human oversight works only when a person can understand, decide and intervene at the right time.

Incorrect Answers

A:

Stop high-severity deployments when credible harms exceed accepted residual-risk limits. Not selected. That response contains a different failure mode and leaves the stated risk unresolved. It belongs with Risk severity and probability matrix: Low observed frequency in a limited test cannot automatically dismiss a severe AI hazard. The present case instead concerns Human-in-the-loop design.

C:

Disable the harmful capability if residual risk remains beyond tolerance after feasible mitigation. Not selected. That response contains a different failure mode and leaves the stated risk unresolved. It belongs with Risk mitigation hierarchy: Risk treatment should prioritize effective hazard reduction over disclaimers that shift burden to users. The present case instead concerns Human-in-the-loop design.

D:

Do not approve development scope until benefits, user responsibilities and safety constraints are defined. Not selected. That response contains a different failure mode and leaves the stated risk unresolved. It belongs with Use-case problem framing: A defensible AI design begins with the problem and context, not a preference for a model technology. The present case instead concerns Human-in-the-loop design.

Question 617

An AI-assisted diagnostic tool shows clinicians a label but auto-submits orders before they can review the evidence. Model assurance reviewers need a documented control before approving continued experimentation. What should the AI governance lead examine before changing the system?

  1. Examine the actual intervention point, reviewer workload, authority and automation-bias risk.
  2. Identify affected populations, possible disparate impacts, appeal routes and missing stakeholder views.
  3. Compare requirements for determinism, explainability, resource cost, data needs and failure modes.
  4. Trace trust boundaries from uploaded content to model prompts, tool calls and authorized business actions.

Explanation

Correct Answer

A:

Examine the actual intervention point, reviewer workload, authority and automation-bias risk. Correct. It establishes the relevant factual risk boundary before implementation. Human oversight works only when a person can understand, decide and intervene at the right time.

Incorrect Answers

B:

Identify affected populations, possible disparate impacts, appeal routes and missing stakeholder views. Not selected. That check primarily diagnoses a different governance issue. It belongs with Stakeholder impact assessment: Impact assessment should consider people and groups who bear risk, not only the organization buying AI. The present case instead concerns Human-in-the-loop design.

C:

Compare requirements for determinism, explainability, resource cost, data needs and failure modes. Not selected. That check primarily diagnoses a different governance issue. It belongs with System architecture and model choice: Model selection is a governance choice about fit, controllability and risk, not model prestige. The present case instead concerns Human-in-the-loop design.

D:

Trace trust boundaries from uploaded content to model prompts, tool calls and authorized business actions. Not selected. That check primarily diagnoses a different governance issue. It belongs with Generative AI misuse threat model: Generative AI development requires threat modeling for instruction confusion and downstream actions. The present case instead concerns Human-in-the-loop design.

Question 618

An AI-assisted diagnostic tool shows clinicians a label but auto-submits orders before they can review the evidence. Model assurance reviewers need a documented control before approving continued experimentation. What is the most directly applicable governance control for this situation?

  1. Threat-model prompt injection and data exfiltration; segregate instructions, restrict tools and validate outputs.
  2. Write a bounded use-case specification with human authority, exclusions and measurable patient-safety objectives.
  3. Maintain a versioned design record of purpose, alternatives, constraints, risk choices and responsible approvers.
  4. Insert an effective clinician review and override before consequential orders are committed.

Explanation

Correct Answer

D:

Insert an effective clinician review and override before consequential orders are committed. Correct. It directly reduces or governs the specific documented risk. Human oversight works only when a person can understand, decide and intervene at the right time.

Incorrect Answers

A:

Threat-model prompt injection and data exfiltration; segregate instructions, restrict tools and validate outputs. Not selected. That action treats another control objective, not the specific gap described. It belongs with Generative AI misuse threat model: Generative AI development requires threat modeling for instruction confusion and downstream actions. The present case instead concerns Human-in-the-loop design.

B:

Write a bounded use-case specification with human authority, exclusions and measurable patient-safety objectives. Not selected. That action treats another control objective, not the specific gap described. It belongs with Use-case problem framing: A defensible AI design begins with the problem and context, not a preference for a model technology. The present case instead concerns Human-in-the-loop design.

C:

Maintain a versioned design record of purpose, alternatives, constraints, risk choices and responsible approvers. Not selected. That action treats another control objective, not the specific gap described. It belongs with Design record and decision provenance: Design documentation makes technical tradeoffs governable and defensible across staff changes. The present case instead concerns Human-in-the-loop design.

Question 619

An AI-assisted diagnostic tool shows clinicians a label but auto-submits orders before they can review the evidence. Model assurance reviewers need a documented control before approving continued experimentation. What should an independent reviewer test before signing off on this specific risk?

  1. Challenge the system with adversarial documents and confirm no secret disclosure or unauthorized tool action.
  2. Re-score representative edge cases and confirm treatment priority follows the approved risk rubric.
  3. Measure performance on representative cohorts using the exact proposed production threshold.
  4. Test whether clinicians can reject the suggestion without workflow pressure and log their rationale.

Explanation

Correct Answer

D:

Test whether clinicians can reject the suggestion without workflow pressure and log their rationale. Correct. It yields measurable evidence that the case-specific safeguard works. Human oversight works only when a person can understand, decide and intervene at the right time.

Incorrect Answers

A:

Challenge the system with adversarial documents and confirm no secret disclosure or unauthorized tool action. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Generative AI misuse threat model: Generative AI development requires threat modeling for instruction confusion and downstream actions. The present case instead concerns Human-in-the-loop design.

B:

Re-score representative edge cases and confirm treatment priority follows the approved risk rubric. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Risk severity and probability matrix: Low observed frequency in a limited test cannot automatically dismiss a severe AI hazard. The present case instead concerns Human-in-the-loop design.

C:

Measure performance on representative cohorts using the exact proposed production threshold. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Thresholds and acceptance metrics: Governance metrics should reflect the actual harm of error types, not aggregate accuracy alone. The present case instead concerns Human-in-the-loop design.

Question 620

An AI-assisted diagnostic tool shows clinicians a label but auto-submits orders before they can review the evidence. Model assurance reviewers need a documented control before approving continued experimentation. What is the most relevant fallback when the promised safeguard cannot be demonstrated?

  1. Disable the harmful capability if residual risk remains beyond tolerance after feasible mitigation.
  2. Reopen high-impact design decisions lacking material evidence before final approval.
  3. Pause expansion until material affected-group impacts receive assessment and response.
  4. Disable auto-ordering where meaningful clinical oversight is absent.

Explanation

Correct Answer

D:

Disable auto-ordering where meaningful clinical oversight is absent. Correct. It limits further reliance or exposure while the risk remains unresolved. Human oversight works only when a person can understand, decide and intervene at the right time.

Incorrect Answers

A:

Disable the harmful capability if residual risk remains beyond tolerance after feasible mitigation. Not selected. That response contains a different failure mode and leaves the stated risk unresolved. It belongs with Risk mitigation hierarchy: Risk treatment should prioritize effective hazard reduction over disclaimers that shift burden to users. The present case instead concerns Human-in-the-loop design.

B:

Reopen high-impact design decisions lacking material evidence before final approval. Not selected. That response contains a different failure mode and leaves the stated risk unresolved. It belongs with Design record and decision provenance: Design documentation makes technical tradeoffs governable and defensible across staff changes. The present case instead concerns Human-in-the-loop design.

C:

Pause expansion until material affected-group impacts receive assessment and response. Not selected. That response contains a different failure mode and leaves the stated risk unresolved. It belongs with Stakeholder impact assessment: Impact assessment should consider people and groups who bear risk, not only the organization buying AI. The present case instead concerns Human-in-the-loop design.

Artificial Intelligence Governance Professional (AIGP) Practice Tests